Andrew Conrad

Background

Andrew Conrad PhD is a General Partner at S32, joining the firm in February 2024 after founding and leading Verily (formerly Google Life Sciences), Alphabet's healthcare division. He previously served at GV and Google X and was Chief Scientific Officer at LabCorp, where he co-founded the National Genetics Institute. He holds a BS in neurobiology and PhD in cell biology from UCLA. His work spans precision medicine, genomics, and health technology investing.

Investment Focus